Vall d'Hebron Institute of Oncology, Spain

Dr. Laura Soucek is ICREA Research Professor, Associate Professor at the Universidad Autonoma de Barcelona and Head of the Mouse Models of Cancer Therapies Group at the Vall d’Hebron Institute of Oncology (VHIO), in Barcelona, Spain. Her main research focus is the Myc oncoprotein, whose deregulation is implicated in almost all human cancer types. Her seminal studies demonstrated that Myc inhibition has a remarkable therapeutic index in different mouse models of cancer, while only causing mild and reversible side effects in normal tissues, suggesting that Myc inhibition could be a viable and effective strategy against most, if not all, types of cancer.
Dr. Soucek has published in some of the most prestigious international journals including Nature, Nature Genetics, Nature Medicine and Nature Communications. She received prestigious awards and grants, including recognitions by AACR, Worldwide Cancer Research and the European Research Council (ERC). In December 2014 she founded a spin-off company called Peptomyc, which aims at treating cancer with anti-Myc peptides, and in 2016 she assumed the position of Chief-Executive-Officer of the company.